BECN1 and pancreatic neoplasm: The research about pancreatic cancer stem cells found that [79] rottlerin could reduce the viability of pancreatic cancer stem cells and induce apoptosis to form cytoplasm cavity and upregulate autophagy markers LC3-I, LC3-II, Atg7, and Beclin-1.